# PROMISE: Percutaneous peRipheral cannulatiOn for Minimally-InvaSive Heart Valve surgEry

> **NCT05961150** · — · RECRUITING · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 1000 (estimated)

## Conditions studied

- Heart Valve Diseases
- Mitral Valve Disease
- Aortic Valve Disease
- Tricuspid Valve Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05961150
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2024-09
- **Final completion:** 2024-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05961150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05961150, "PROMISE: Percutaneous peRipheral cannulatiOn for Minimally-InvaSive Heart Valve surgEry". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05961150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*